Menu

CDC Director Resigns Over Unresolved Conflicts of Interest

Brenda Fitzgerald had drawn criticism for tobacco-related investments, among others.

Jan 31, 2018
Shawna Williams

FLICKR, RAED MANSOURFollowing a report by Politico that she had purchased shares in tobacco, pharmaceutical, and health insurance companies early in her tenure as director of the Centers for Disease Control (CDC), Brenda Fitzgerald resigned from the agency today (January 31). Fitzgerald had previously been criticized by Senator Patty Murray (D-WA) for financial investments that led her to recuse herself from involvement in some aspects of CDC’s work, The Washington Post reports.

See “Trump Administration Chooses New CDC Director

“You don’t buy tobacco stocks when you are the head of the CDC,” Richard Painter, a former chief ethics lawyer for George W. Bush, tells Politico. “It’s ridiculous; it gives a terrible appearance.”

According to a Department of Health and Human Services statement announcing the departure, “Dr. Fitzgerald owns certain complex financial interests that have imposed a broad recusal limiting her ability to complete all of her duties as the CDC Director. Due to the nature of these financial interests, Dr. Fitzgerald could not divest from them in a definitive time period.”

Before assuming the CDC post in July 2017, Fitzgerald had worked as an obstetrician-gynecologist. She had also served as a major in the Air Force and as chief of Georgia’s state health department.

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing